BMC Medicine 'Under Review': What Each Status Means and When to Expect a Decision

Before the paper reaches external reviewers, a BMC Medicine handling editor evaluates whether the work meets the broad clinical, public-health, or policy readership bar. About 70 to 80 percent of submissions are desk-rejected at this stage within the 3-day median to first editorial decision.

A desk rejection most often means the editor concluded that the work is too specialist for a broad clinical, public-health, or policy readership, or would fit better at a sister BMC journal (BMC Public Health, BMC Family Practice, BMC Health Services Research, BMC Infectious Diseases, BMC Cancer, etc.).

The BMC Medicine editorial office confirms that the clinical manuscript package is complete before a handling editor evaluates fit. For a typical research article, this means the manuscript file, figures, supplementary methods, CONSORT checklist for clinical trials, STROBE checklist for observational studies, PRISMA checklist for systematic reviews, ethics approvals, trial-registration information, conflict-of-interest statements, and data-availability language are all present and internally consistent.

The handling editor reads the paper and evaluates scope fit (BMC Medicine general-medicine broad readership), clinical relevance, and BMC Medicine subspecialty routing. The 3-day median to first editorial decision reflects BMC Medicine's fast triage approach.

In parallel with the handling editor's primary read, ambiguous-fit papers are discussed across the BMC editorial team where peer handling editors and academic associate editors weigh in on whether the paper would fit better at BMC Medicine flagship or at sister BMC journals. This editorial-team discussion runs alongside the desk-screen and adds 2 to 4 days to the timeline that is invisible to the author in the portal.

BMC Medicine handling editors typically invite 2 to 3 external reviewers, with reviewer recruitment typically taking 7 to 14 days. The transparent peer review model means reviewer reports become public alongside accepted papers, though reviewer names are not published. The recruitment window can take longer because reviewers willing to have their reports published are scarcer than reviewers for anonymous review.

Once reviewers agree to review, the typical BMC Medicine peer-review cycle lasts 4 to 8 weeks per reviewer. Reviewers are asked to evaluate clinical relevance, broad readership fit, methodological rigor, novelty, and BMC Medicine editorial identity fit. Papers that reach peer review face a different bar: novelty, rigor, and fit with the journal's editorial identity. Reviewer reports for BMC Medicine tend to be thorough; 2000 to 4000 word reports are typical given the transparent peer review (knowing reports will be published).

After reports return, the handling editor synthesizes them. Total submission-to-acceptance commonly runs 4 to 8 months for successful papers, including revision rounds.

• Rejection within 1 to 3 days: BMC handling editor desk rejection per the 3-day median (most common rejection timing).

• Rejection within 3 to 7 days: Extended editorial team discussion desk rejection.

• Still Under Review after 1 week: Strong signal. Paper passed the BMC Medicine handling editor desk screen.

• Still Under Review after 10 weeks: Reviewer-recruitment or reviewer-report delay. A polite inquiry via the Editorial Manager portal is appropriate.

• Status changes to "Decision in Process": Reports are in; expect a decision within 1 to 2 weeks.

For BMC Medicine authors, the 6-week status check has a specific meaning because the journal's first editorial decision median is fast while post-screen review still depends on reviewer recruitment. Six weeks at Under Review usually means the paper cleared the broad-readership screen and is somewhere between active reviewer work and editorial synthesis.

The transparent peer-review model adds a real friction point: reviewers know their reports may be published alongside accepted papers, so recruitment can take longer than a private-review journal. If the portal still says Under Review at the 10-week mark, the most likely explanation is a reviewer extension or replacement.

During the 6-to-10-week window, do not email the editorial office unless there is an ethics update, data-correction issue, or institutional deadline that truly changes the manuscript record. A status-only inquiry at 6 weeks rarely accelerates a transparent peer-review file because the slow step is usually reviewer availability or report synthesis, not an overlooked author task.

If your BMC Medicine paper is rejected after review, the natural cascade depends on what the reviewers and editor cited:

BMC Public Health is the natural BMC cascade for public-health-focused work.

BMC Family Practice is the BMC cascade for primary-care papers.

BMC Health Services Research is the BMC cascade for health-services research.

BMC Infectious Diseases is the BMC cascade for infectious-diseases papers.

BMC Cancer is the BMC cascade for cancer-research papers.

BMC Research Notes is the BMC short-format cascade.

The Lancet is the external Lancet general-medicine cascade for top-tier global-clinical-impact work. The Lancet uses Editorial Manager at Editorial Manager submission portal; editorial contact editorial@lancet.com.

The BMJ is the external BMJ general-medicine cascade. The BMJ uses ScholarOne at ScholarOne submission portal; editorial contact editorial@bmj.com.

PLOS Medicine is the external PLOS general-medicine cascade. PLOS Medicine uses Editorial Manager at Editorial Manager submission portal; editorial contact plosmedicine@plos.org.

BMC asks reviewers at BMC Medicine to evaluate four things specifically. The table below maps each to actionable preparation.

In our pre-submission work with BMC Medicine-targeted manuscripts, three named patterns generate the most consistent reviewer concerns and the most common reasons papers miss the editorial bar or fail the desk screen.

Too-specialist framing flagged at BMC handling editor screen. When the BMC Medicine introduction frames the work too specialist for a broad clinical, public-health, or policy readership, handling editor desk rejection within the fast first-decision window is common. The strongest manuscripts make the broad-readership relevance visible in the title, abstract, and first figure, then explain why the finding changes a clinical, public-health, or policy decision beyond one specialty.

If the result reads like a specialist cohort note, it usually fits a narrower BMC journal better than BMC Medicine.

Check whether your BMC Medicine broad-readership framing is clear →

Reporting checklist gaps surface as reviewer concerns. When CONSORT, STROBE, or PRISMA checklists are incomplete, BMC Medicine reviewers consistently request expanded methods, cohort-flow, endpoint, and sensitivity-analysis sections. We see this most often when the supplementary file contains the checklist but the manuscript text does not let a reader verify the sample definition, missing-data handling, or endpoint hierarchy. The strongest submissions make each checklist item traceable to methods, results, and supplement text before the handling editor sends the paper out.

Check your BMC Medicine reporting-checklist package →

BMC family cascade offers from handling editor. When the BMC Medicine handling editor concludes the work is rigorous but the broad-readership bar is not met, transfer offers to BMC Public Health, BMC Primary Care, BMC Health Services Research, BMC Infectious Diseases, or BMC Cancer are common. BMC editors take these transfers seriously, but the right response depends on whether the limitation is audience breadth, clinical consequence, study design, or transparent-review readiness.

A transfer works best when the cover letter and abstract are rebuilt for the receiving journal rather than sent unchanged.

Check whether BMC Medicine or a BMC sister journal is the better route →

We have reviewed 50+ manuscripts targeting BMC Medicine, BMJ Open, PLOS Medicine, Scientific Reports, and BMC specialty journals. This guide tells you what BMC Medicine editors look for in the status window, while the review tells you whether your paper passes the same broad-readership, methods, reporting-checklist, and transparent-review checks before the handling editor or external reviewers see it. Full Manusights reviews include a 60-day money-back guarantee, and we do not train models on your manuscript.

We have found that the strongest BMC Medicine revisions rebuild the abstract and first figure around a broad clinical, public-health, or policy decision point before trying to defend specialist detail.

In our pre-submission review work across broad-medicine, public-health, and open-access medical targets, BMC Medicine-bound drafts most often failed when the paper looked methodologically competent but too specialist for BMC Medicine's general clinical readership. We see this as a recurring failure pattern because editors can redirect a sound study if the abstract and first figure do not make the public-health or policy consequence obvious.

Source limitation: official guidance explains BMC Medicine submission and peer-review requirements, but it cannot diagnose whether your specific clinical claim is broad enough for the flagship journal.

Use this guide when you need to separate normal BMC Medicine review silence from a true follow-up moment before you submit, withdraw, or prepare a BMC transfer plan.

This page was created from BMC's public BMC Medicine submission guidelines at Springer Nature author instructions, BMC editorial policies (3-day median first editorial decision, 5 to 8 percent overall acceptance, 70 to 80 percent desk rejection rate for too-specialist work, transparent peer review with reviewer reports published but reviewer name not published, 2 to 3 reviewers per submission), and Manusights pre-submission review experience with BMC Medicine-targeted manuscripts.

For the open-access general-medicine landscape beyond BMC Medicine, see BMC Public Health (public-health), BMC Family Practice (primary-care), BMC Health Services Research (health-services), BMC Infectious Diseases (infectious-diseases), BMC Cancer (cancer), BMC Research Notes (short-format), and external open-access general-medicine alternatives (BMJ Open, PLOS Medicine, Scientific Reports).

The choice across these titles depends on whether the central contribution is broad clinical-public-health-policy (BMC Medicine), public-health (BMC Public Health), primary-care (BMC Family Practice), health-services (BMC Health Services Research), infectious-diseases (BMC Infectious Diseases), cancer (BMC Cancer), short-format (BMC Research Notes), BMJ open-access (BMJ Open), top PLOS general-medicine (PLOS Medicine), or Nature Portfolio open-access (Scientific Reports).

Reviewers at BMC Medicine typically draw from 2 to 3 general-medicine specialists under a transparent peer-review model (reports public, reviewer not named). Editors screen and triage manuscripts before any reviewer sees them, and preparing a response template that addresses broad-readership relevance and reporting-checklist compliance accelerates revision rounds substantially.

For a pre-upload check of your manuscript against the BMC Medicine broad-readership bar before submission, our BMC Medicine pre-submission diagnostic flags the framing and reporting-checklist weaknesses most likely to surface in reviewer reports.